XTalks

JULY 26, 2024

XTALKS WEBINAR: Changes are Coming to Prefilled Injectable Drug Delivery Systems Live and On-Demand: Thursday, September 12, 2024, at 1pm EDT (10am PDT) Register for this webinar today to learn more about the future of injectable drug delivery systems and the impact of blow-fill-seal technology.

Drug Delivery Systems 97

Drug Delivery Systems FDA Approval Drug Delivery Containment 97

XTalks

JUNE 14, 2023

XTALKS WEBINAR: Drug Delivery — Evaluating Off-The-Shelf and Novel Drug Delivery Solutions Live and On-Demand: Tuesday, July 11, 2023, at 1pm EDT (10am PDT) Register for this free webinar to learn about important tradeoffs when considering an off-the-shelf (OTS) drug delivery platform vs. novel development.

Gene Silencing 97

Gene Silencing Drug Delivery FDA Approval RNA 97

XTalks

JANUARY 17, 2023

The US Food and Drug Administration (FDA) granted approval to AstraZeneca’s Airsupra (albuterol/budesonide), formerly known as PT027, for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of asthma attacks in individuals aged 18 years and older who have asthma.

FDA Approval 97

FDA Approval Containment Allergies Drugs 97

XTalks

AUGUST 30, 2022

Whether you are a director, manager or hold a C-suite role within a pharma, biotech, medical device or life science organization, it is important to understand which leadership styles are currently gaining much influence in the industry. Visionary Leadership. A visionary sees what no one else can see especially in the present time.

Life Science 105

Life Science Generic Drugs Drug Delivery Compliance 105

XTalks

JULY 28, 2020

Excipients can take many forms, such as bulking agents, binders, coatings and colourants, and they are chosen based on their ability to aid in drug delivery, administration and even in pill identification and prevention of counterfeiting. But just how inert are these excipients?

Protein 103

Protein Drugs In-Vitro Scientist 103

The Pharma Data

JANUARY 27, 2021

CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (“ XPhyto ” or the “ Company “) is pleased to announce its drug formulation and delivery business strategy and milestones for 2021. Vektor will begin planning and development work for the incorporation of various psychedelic compounds into its drug formulations.

Drugs 52

Drugs Manufacturing Drug Delivery Production 52

The Pharma Data

NOVEMBER 4, 2020

CorpCann is a Norwegian-based international investment and consulting firm focused on European and North American opportunities in the life science, nutraceutical, aquaculture and energy industries. XPhyto is also pleased to announce a strategic European advisor engagement with CorpCann AS (“CorpCann”).

Drug Delivery 40

Drug Delivery Production Manufacturing Development 40